Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | %Female (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
157 | Cancer Immunity | journal | 0.327 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
156 | Cancer Journal | journal | 1.325 Q1 | 16 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
155 | Electronic Journal of Oncology | journal | 0.111 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
154 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.181 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
153 | European Journal of Cancer, Supplement | journal | 29 | 51 | 0 | 2131 | 0 | 0 | 0.00 | 41.78 | 25.33 | ||
152 | International Journal of Pediatric Hematology/Oncology | journal | 0.101 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
151 | Progress in Experimental Tumor Research | book series | 20 | 14 | 0 | 1453 | 0 | 0 | 0.00 | 103.79 | 24.00 | ||
150 | Journal of Carcinogenesis | journal | 0.121 Q4 | 43 | 9 | 1 | 372 | 0 | 1 | 0.00 | 41.33 | 39.29 | |
149 | Oncology Forum | journal | 0.103 Q4 | 1 | 31 | 7 | 219 | 0 | 6 | 0.00 | 7.06 | 28.57 | |
148 | Pathogenesis | journal | 0.215 Q4 | 8 | 0 | 7 | 0 | 5 | 7 | 0.00 | 0.00 | 0.00 | |
147 | Leukaemia Risks in Relation to Benzene Exposure | conference and proceedings | 0.102 | 1 | 0 | 9 | 0 | 0 | 9 | 0.00 | 0.00 | 0.00 | |
146 | Molecular Cancer | journal | 0.618 Q3 | 196 | 42 | 9 | 2489 | 26 | 8 | 2.89 | 59.26 | 25.76 | |
145 | Critical Reviews in Oncogenesis | journal | 1.503 Q1 | 57 | 0 | 11 | 0 | 44 | 11 | 0.00 | 0.00 | 0.00 | |
144 | National Toxicology Program technical report series | journal | 0.101 | 22 | 3 | 13 | 0 | 1 | 13 | 0.00 | 0.00 | 0.00 | |
143 | Gann Monographs on Cancer Research | book series | 0.101 Q4 | 10 | 29 | 17 | 1476 | 0 | 16 | 0.00 | 50.90 | 19.61 | |
142 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 17 | 598 | 3 | 17 | 0.00 | 149.50 | 14.75 | ||
141 | Women's Oncology Review | journal | 0.108 | 4 | 12 | 17 | 349 | 1 | 13 | 0.06 | 29.08 | 60.00 | |
140 | Journal of Cancer Research and Clinical Oncology, Supplement | journal | 1.017 Q2 | 13 | 0 | 18 | 0 | 65 | 18 | 3.61 | 0.00 | 0.00 | |
139 | Cancer Cell International | journal | 0.340 Q3 | 80 | 17 | 19 | 689 | 20 | 18 | 1.05 | 40.53 | 36.00 | |
138 | Tumor Research | journal | 0.130 Q4 | 3 | 3 | 19 | 51 | 4 | 19 | 0.00 | 17.00 | 38.89 | |
137 | Journal of Cancer Epidemiology and Prevention | journal | 0.482 Q3 | 10 | 0 | 22 | 0 | 25 | 22 | 1.14 | 0.00 | 0.00 | |
136 | Annals of Cancer Research and Therapy | journal | 0.104 Q4 | 7 | 20 | 23 | 554 | 1 | 22 | 0.11 | 27.70 | 9.68 | |
135 | Cancer Immunology Research | journal | 134 | 22 | 29 | 515 | 39 | 26 | 1.34 | 23.41 | 34.33 | ||
134 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 6 | 30 | 831 | 20 | 29 | 0.58 | 138.50 | 25.00 | ||
133 | Familial Cancer | journal | 0.339 Q3 | 67 | 19 | 32 | 726 | 19 | 29 | 0.59 | 38.21 | 45.88 | |
132 | Current Cancer Drug Targets | journal | 1.097 Q2 | 103 | 39 | 36 | 3957 | 140 | 36 | 3.89 | 101.46 | 27.84 | |
131 | Journal of Tumor Marker Oncology | journal | 0.100 Q4 | 9 | 0 | 37 | 0 | 0 | 37 | 0.00 | 0.00 | 0.00 | |
130 | Journal of Experimental Therapeutics and Oncology | journal | 0.345 Q3 | 40 | 31 | 38 | 1473 | 39 | 37 | 1.03 | 47.52 | 27.27 | |
129 | Cancer Molecular Biology | journal | 0.101 Q4 | 4 | 3 | 40 | 87 | 1 | 40 | 0.00 | 29.00 | 55.56 | |
128 | Reports of Practical Oncology and Radiotherapy | journal | 0.121 Q4 | 36 | 15 | 40 | 444 | 8 | 37 | 0.17 | 29.60 | 31.58 | |
127 | Hematological Oncology | journal | 0.866 Q2 | 54 | 20 | 44 | 688 | 100 | 44 | 2.46 | 34.40 | 30.00 | |
126 | Cancer Research, Therapy and Control | journal | 0.152 Q4 | 13 | 0 | 47 | 0 | 9 | 47 | 0.25 | 0.00 | 0.00 | |
125 | Onkologia Polska | journal | 0.117 Q4 | 7 | 30 | 48 | 671 | 4 | 48 | 0.08 | 22.37 | 45.12 | |
124 | Prostate Journal | journal | 0.266 Q4 | 7 | 0 | 48 | 0 | 17 | 43 | 0.35 | 0.00 | 0.00 | |
123 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 0.225 Q4 | 35 | 14 | 49 | 525 | 72 | 49 | 1.47 | 37.50 | 16.67 | |
122 | Current Problems in Cancer | journal | 0.343 Q3 | 47 | 25 | 49 | 761 | 43 | 46 | 1.33 | 30.44 | 22.22 | |
121 | UroOncology | journal | 0.118 Q4 | 5 | 25 | 51 | 558 | 3 | 45 | 0.06 | 22.32 | 25.00 | |
120 | Advances in Cancer Research | journal | 4.758 Q1 | 109 | 23 | 57 | 4131 | 457 | 57 | 8.17 | 179.61 | 34.78 | |
119 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.906 Q2 | 108 | 41 | 57 | 4139 | 140 | 55 | 2.46 | 100.95 | 26.36 | |
118 | BMC Cancer | journal | 0.664 Q3 | 160 | 32 | 57 | 1272 | 112 | 57 | 1.96 | 39.75 | 34.29 | |
117 | Journal of the National Cancer Institute. Monographs | journal | 2.159 Q1 | 95 | 19 | 57 | 843 | 345 | 56 | 4.72 | 44.37 | 44.44 | |
116 | Angiogenesis | journal | 1.104 Q2 | 101 | 38 | 59 | 1537 | 149 | 58 | 2.53 | 40.45 | 30.38 | |
115 | Journal of Brachytherapy International | journal | 0.305 Q3 | 12 | 0 | 62 | 0 | 31 | 61 | 0.52 | 0.00 | 0.00 | |
114 | Technology in Cancer Research and Treatment | journal | 0.206 Q4 | 72 | 66 | 62 | 3135 | 62 | 61 | 1.00 | 47.50 | 22.08 | |
113 | Nowotwory | journal | 0.107 Q4 | 11 | 57 | 63 | 1586 | 5 | 63 | 0.13 | 27.82 | 34.92 | |
112 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 6.667 Q1 | 159 | 10 | 65 | 1653 | 700 | 65 | 11.40 | 165.30 | 25.00 | |
111 | Brain Tumor Pathology | journal | 0.371 Q3 | 45 | 16 | 67 | 358 | 65 | 67 | 0.84 | 22.38 | 13.79 | |
110 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.174 Q4 | 50 | 0 | 70 | 0 | 33 | 70 | 0.62 | 0.00 | 0.00 | |
109 | Sub-Cellular Biochemistry | journal | 0.926 Q2 | 81 | 0 | 72 | 0 | 109 | 72 | 1.44 | 0.00 | 0.00 | |
108 | Turkish Journal of Cancer | journal | 0.110 Q4 | 10 | 26 | 72 | 524 | 5 | 72 | 0.06 | 20.15 | 39.45 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®